Cargando…

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data

BACKGROUND: Darunavir is a second-generation protease inhibitor and is registered for the treatment of HIV-1 infection. The aim of this study was to develop and validate a darunavir population pharmacokinetic model based on data from daily practice. METHODS: Data sets were obtained from 2 hospitals:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daskapan, Alper, Tran, Quynh T.D., Cattaneo, Dario, Gervasoni, Cristina, Resnati, Chiara, Stienstra, Ymkje, Bierman, Wouter F.W., Kosterink, Jos G. W., van der Werf, Tjip S., Proost, Johannes H., Alffenaar, Jan-Willem C., Touw, Daniel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Therapeutic Drug Monitoring 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358182/ https://www.ncbi.nlm.nih.gov/pubmed/30489547 http://dx.doi.org/10.1097/FTD.0000000000000576

Ejemplares similares

Risk factors contributing to a low darunavir plasma concentration
por: Daskapan, Alper, et al.
Publicado: (2017)

Food intake and darunavir plasma concentrations in people living with HIV in an outpatient setting
por: Daskapan, Alper, et al.
Publicado: (2017)

Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting
por: van’t Boveneind-Vrubleuskaya, Natasha, et al.
Publicado: (2016)

Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study
por: Ghimire, Samiksha, et al.
Publicado: (2020)

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs
por: Daskapan, Alper, et al.
Publicado: (2018)

Relevance of the drug–drug interactions between lidocaine and the pharmacokinetic enhancers ritonavir and cobicistat
por: Dekkers, Bart G.J., et al.
Publicado: (2019)

Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis
por: Saktiawati, Antonia Morita I., et al.
Publicado: (2019)

Sensitivity and specificity of routine diagnostic work-up for tuberculosis in lung clinics in Yogyakarta, Indonesia: a cohort study
por: Saktiawati, Antonia Morita I., et al.
Publicado: (2019)

Caspofungin Weight-Based Dosing Supported by a Population Pharmacokinetic Model in Critically Ill Patients
por: Märtson, Anne-Grete, et al.
Publicado: (2020)

Long Term Streptomycin Toxicity in the Treatment of Buruli Ulcer: Follow-up of Participants in the BURULICO Drug Trial
por: Klis, Sandor, et al.
Publicado: (2014)

Wound Care in Buruli Ulcer Disease in Ghana and Benin
por: Velding, Kristien, et al.
Publicado: (2014)

Sensitivity and specificity of an electronic nose in diagnosing pulmonary tuberculosis among patients with suspected tuberculosis
por: Saktiawati, Antonia M. I., et al.
Publicado: (2019)

In-vitro Activity of Avermectins against Mycobacterium ulcerans
por: Omansen, Till F., et al.
Publicado: (2015)

Comment on “Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6”
por: Cattaneo, Dario, et al.
Publicado: (2021)

Ganciclovir Therapeutic Drug Monitoring: A Case Series
por: Märtson, Anne-Grete, et al.
Publicado: (2019)

Yield of yearly routine physical examination in HIV-1 infected patients is limited: A retrospective cohort study in the Netherlands
por: van Amsterdam, Marleen A., et al.
Publicado: (2017)

Darunavir does not prevent SARS-CoV-2 infection in HIV patients
por: Riva, Agostino, et al.
Publicado: (2020)

Quality of interhospital transport of critically ill patients: a prospective audit
por: Ligtenberg, Jack JM, et al.
Publicado: (2005)

Towards Rational Use of Antibiotics for Suspected Secondary Infections in Buruli Ulcer Patients
por: Barogui, Yves T., et al.
Publicado: (2013)

Practices of therapeutic drug monitoring in tuberculosis: an international survey
por: Margineanu, Ioana, et al.
Publicado: (2022)

Good Quality of Life in Former Buruli Ulcer Patients with Small Lesions: Long-Term Follow-up of the BURULICO Trial
por: Klis, Sandor, et al.
Publicado: (2014)

The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019
por: Pranger, A. D., et al.
Publicado: (2019)

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams
por: Bolhuis, Mathieu S., et al.
Publicado: (2011)

Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations
por: Märtson, Anne‐Grete, et al.
Publicado: (2019)

Former Buruli Ulcer Patients’ Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management
por: Velink, Anita, et al.
Publicado: (2016)

Genetic Diversity of Staphylococcus aureus in Buruli Ulcer
por: Amissah, Nana Ama, et al.
Publicado: (2015)

Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer
por: Barogui, Yves Thierry, et al.
Publicado: (2016)

Perceptions on the Effectiveness of Treatment and the Timeline of Buruli Ulcer Influence Pre-Hospital Delay Reported by Healthy Individuals
por: Alferink, Marike, et al.
Publicado: (2013)

Molecular Characterization of Staphylococcus aureus Isolates Transmitted between Patients with Buruli Ulcer
por: Amissah, Nana Ama, et al.
Publicado: (2015)

Epidemiology of Staphylococcus aureus in a burn unit of a tertiary care center in Ghana
por: Amissah, Nana Ama, et al.
Publicado: (2017)

Assessment and Treatment of Pain during Treatment of Buruli Ulcer
por: de Zeeuw, Janine, et al.
Publicado: (2015)

High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015
por: Ravensbergen, Sofanne J., et al.
Publicado: (2016)

Cutaneous Larva Migrans Acquired in Brittany, France
por: Tamminga, Nienke, et al.
Publicado: (2009)

Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

In vitro evaluation of an intravenous microdialysis catheter for therapeutic drug monitoring of gentamicin and vancomycin
por: van der Mast, Jackelien E., et al.
Publicado: (2019)

Darunavir in experienced patients
por: Sterrantino, G, et al.
Publicado: (2010)

Psychometric Properties of the Participation Scale among Former Buruli Ulcer Patients in Ghana and Benin
por: de Zeeuw, Janine, et al.
Publicado: (2014)

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
por: Marin, Ruxandra-Cristina, et al.
Publicado: (2021)

Cobicistat/darunavir/cobicistat/darunavir/emtricitabine/tenofovir-alafenamide/darunavir/ritonavir: Various toxicities and off-label use: 9 case reports
Publicado: (2020)

A scabies outbreak in the North East Region of Ghana: The necessity for prompt intervention
por: Amoako, Yaw Ampem, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tv31hju0huc3cd6epg01v2524d